Overview

Tessa Therapeutics is a clinical-stage biotechnology company developing a portfolio of novel next-generation cell therapies for cancer.

Tessa is leading the way in CD30 targeting using cell therapy. CD30 is a well validated lymphoma target with homogenous expression in Classical Hodgkin Lymphoma and multiple subsets of non-Hodgkin Lymphomas. Tessa’s approach to target CD30-positive cancers using CAR-T (Chimeric Antigen Receptor) cells has demonstrated excellent safety and efficacy in early clinical trials. Having received the RMAT and PRIME designation, Tessa is now advancing the therapy to a pivotal trial.

Off-the-shelf allogeneic cell therapy has significant advantages and is the next frontier in cancer treatment. Tessa is developing a unique and potentially transformational allogeneic CD30-CAR EBVST platform capable of targeting a broad range of cancers. This platform is based on decades-long research and development on unique properties of Virus Specific T-cells (VSTs) by our Scientific Co-Founder, Dr. Malcolm Brenner, and his team at Baylor College of Medicine.

Tessa is proud to be innovators in the field of cancer immunotherapy, and remains committed to making a difference in the lives of cancer patients worldwide. Our global headquarters are in Singapore, where we are building our own state-of-the-art commercial manufacturing facility. We are also currently setting up our United States headquarters in New Jersey.

tt-img-sab-malcolm-20201217

Malcolm K. Brenner,
M.D., Ph.D.

Scientific Co-Founder & Advisor

Our Leadership

Jeffrey H. Buchalter
President and Chief Executive Officer
Learn More >>
Ivan D. Horak, M.D.
EVP, Chief Medical Officer and Chief Scientific Officer
Learn More >>
David McIntyre
EVP, Chief Financial Officer
Learn More >>
John Ng
EVP, Chief Technical Officer
Learn More >>

Board of Directors

Dr. Göran Ando
Chairman
Learn More >>
Mr. Jeffrey H. Buchalter
President and Chief Executive Officer
Learn More >>
Dr. Fidah Alsagoff
Director
Learn More >>
Dr. George W. Sledge
Director
Learn More >>
Dr. Gabriela Gruia
Director
Learn More >>

Scientific Advisory Board

Malcolm K. Brenner, M.D., Ph.D.
Scientific Co-Founder & Scientific Advisor
Learn More >>
Giulio F. Draetta, M.D., Ph.D.
Head of Scientific Advisory Board
Learn More >>
Rafi Ahmed, Ph.D.
Scientific Advisor
Learn More >>
Tak W. Mak, Ph.D.
Scientific Advisor
Learn More >>
Waseem Qasim, M.D., Ph.D.
Scientific Advisor
Learn More >>
Pamela Ohashi, Ph.D.
Scientific Advisor
Learn More >>
Lillian L. Siu, M.D.
Scientific Advisor
Learn More >>
Dmitriy Zamarin, M.D., Ph.D.
Scientific Advisor
Learn More >>
Anthony Chan Tak Cheung, M.D.
Scientific Advisor
Learn More >>
Mario Sznol, M.D.
Scientific Advisor
Learn More >>
Josep Tabernero, M.D., Ph.D.
Scientific Advisor
Learn More >>
Louis M. Weiner, M.D.
Scientific Advisor
Learn More >>
Ivan D. Horak, M.D.
Scientific Advisor
Learn More >>

Cell Manufacturing Advisory Board

Marc D. Better, Ph.D.
Cell Manufacturing Advisor
Learn More >>
Cliona M. Rooney, Ph.D.
Cell Manufacturing Advisor
Learn More >>

Strategic Partners

Baylor College of Medicine
Learn More >>
University of North Carolina
Learn More >>
St. Jude Children’s Research Hospital
Learn More >>
National Cancer Centre Singapore
Learn More >>
Agency for Science, Technology and Research
Learn More >>